The pharmaceutical testing, application segment is expected to grow at the highest CAGR from 2020 to 2025.
Pharmaceutical manufacturers and related testing service providers are among the key end users of chromatography reagents. They use analytical instrumentation during various stages of drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies, as well as during the manufacturing of bulk drugs and biological products, drug stability testing, and in qualitative and quantitative pharmaceutical analysis. Increasing R&D for therapeutic areas, such as cancer, HIV/AIDS, and immunodeficiency disorders, technological innovations in biotechnology research, increasing focus of pharmaceutical and biotechnology companies on extending their product pipeline, rising number of drug discovery and clinical trial projects, and patent expiry of blockbuster drugs and biomolecules are some of the key factors driving the growth of this segment. Additionally, the
Chromatography Reagents Market worth $7.8 billion by 2025
iCrowd Newswire
According to the new market research report by Technology (GC, LC, SFC, TLC, and Paper Chromatography), Type (Solvents, Buffers, Derivatization Reagents, Ion-Pair Reagents, and Others), Separation Mechanism, Application - Global Forecast to 2025″, published by MarketsandMarkets™, the Chromatography Reagents Market is projected to reach USD 7.8 billion by 2025 from an estimated USD 5.5 billion in 2020, at a CAGR of 7.1% during the forecast period.
Browse in-depth TOC on
The pharmaceutical testing, application segment is expected to grow at the highest CAGR from 2020 to 2025.
Pharmaceutical manufacturers and related testing service providers are among the key end users of chromatography reagents. They use analytical instrumentation during various stages of drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies, as well as during the manufacturing of bulk dru
Press release content from Business Wire. The AP news staff was not involved in its creation.
Regis Expands Facilities to Support Rising Demand for U.S.-Based Custom API Pharmaceutical Development and Manufacturing
February 17, 2021 GMT
Siead Zegar, Director of Process Chemistry at Regis Technologies, in the company’s 9,000-square-foot expansion of its custom API development laboratories in Morton Grove, IL. (Photo: Business Wire)
Siead Zegar, Director of Process Chemistry at Regis Technologies, in the company’s 9,000-square-foot expansion of its custom API development laboratories in Morton Grove, IL. (Photo: Business Wire)
MORTON GROVE, Ill. (BUSINESS WIRE) Feb 17, 2021
Regis Technologies, Inc. today announced the completion of a major expansion of their laboratory facilities for the development of active pharmaceutical ingredients (APIs) located in Morton Grove, Illinois. The expansion, which doubles the company’s capacity to take on new development projects, is now f